Quantifying and determining the topological distribution of tau is crucial to further understand the progression of tauopathies in vivo, to clarify the role of neurofibrillary tangles in AD along with their Aβ plaques associations, as well as to improve the sensitivity and specificity of diagnosing PSP and CBD. The gene discussed is MAPT; the disease is Alzheimer disease.